Excess body weight—including overweight and obesity—is a significant risk factor for cancer. Research from the American Cancer Society estimates that it contributes to approximately 5 percent of ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.

Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

A team of researchers has developed a "gut-on-chip" (a miniature model of the human intestine on a chip-sized device) capable ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

Registered dietitian Suzanne Fisher offers explains why nutrition is important to support metastatic breast cancer. She ...

Actimed Therapeutics’ anti-catabolic and pro-anabolic transforming agent, S-pindolol benzoate receives US & European patents: London, UK Friday, February 7, 2025, 16:00 Hrs [IST ...

Two new composition of matter patents granted in the US and Europe Patents provide protection relating to lead compound S-pindolol benzoate ...

A $3.2 million grant from the National Institutes of Health is empowering University of Houston researchers to tackle Rhabdomyosarcoma, a malignant soft tissue sarcoma that has a higher incidence in ...

Dr. Yeh will oversee the continued clinical development of NGM Bio’s key programs, NGM120 for hyperemesis gravidarum and cancer cachexia, and ...

Robert Kelly is managing director of XTS Energy LLC, and has more than three decades of experience as a business executive. He is a professor of economics and has raised more than $4.5 billion in ...